09Oct
Caremark Round II: Beware Red Flags in Drug Development
On October 1, 2019, the Delaware Court of Chancery applied the Delaware Supreme Court’s recent decision on Caremark board oversight claims in the context of operating in a highly regulated industry to allow derivative claims to proceed against the...
By:
Goodwin
Related
The ECB was even more aggressive than expected in its moves to “head off a downturn before it gaine...
Read More >
On October 28, 2019, the Ninth Circuit, following in the footsteps of the D.C. Circuit and the Secon...
Read More >
The Dallas City Council recently joined several other major Texas cities in passing a mandatory paid...
Read More >
The Supreme Court of Pennsylvania recently held that the fluctuating workweek method of calculating ...
Read More >
Massachusetts Supreme Judicial Court: No Further Deadline or Statute of Limitations Extensions - On...
Read More >
In Belanger v Western Ventilation Products Ltd, 2019 ABQB 571, a Master of the Alberta Court of Quee...
Read More >